HomeORYZF • OTCMKTS
add
Oryzon Genomics SA
Previous close
$3.28
Year range
$1.57 - $3.28
Market cap
211.67M EUR
Avg Volume
47.00
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 4.22M | 2.73% |
Operating expense | 3.81M | 21.52% |
Net income | -31.27K | -126.91% |
Net profit margin | -0.74 | -126.15% |
Earnings per share | 0.00 | — |
EBITDA | 300.80K | -64.01% |
Effective tax rate | 97.62% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.11M | 208.78% |
Total assets | 138.35M | 25.01% |
Total liabilities | 24.13M | -0.13% |
Total equity | 114.22M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -31.27K | -126.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
47
